Literature DB >> 18427211

Association of HIV infection and Mycobacterium ulcerans disease in Benin.

Roch C Johnson1, Fabienne Nackers, Judith R Glynn, Elisa de Biurrun Bakedano, Claude Zinsou, Julia Aguiar, René Tonglet, Françoise Portaels.   

Abstract

We investigated the association between Buruli ulcer and HIV by comparing the HIV-1/2 seroprevalence in a series of 426 Buruli ulcer patients and a sample of 613 residents of southern Benin. The overall HIV prevalence was 2.6% (11/426) among patients and 0.3% among controls (2/613), giving an odds ratio for the association between HIV and Buruli ulcer of 8.1 (95% confidence interval = 1.8-75; P = 0.003).

Entities:  

Mesh：

Year:  2008        PMID： 18427211     DOI： 10.1097/QAD.0b013e3282f7690a

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  15 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

2.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  [Infections with non-tuberculous mycobacteria in HIV-infected patients].

Authors:  C Herzmann; S Esser; C Lange
Journal:  Hautarzt       Date:  2011-04       Impact factor: 0.751

Review 4.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

5.  Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.

Authors:  Joseph Tuffour; Evelyn Owusu-Mireku; Marie-Therese Ruf; Samuel Aboagye; Grace Kpeli; Victor Akuoku; Janet Pereko; Albert Paintsil; Kofi Bonney; William Ampofo; Gerd Pluschke; Dorothy Yeboah-Manu
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

Review 6.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

7.  Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).

Authors:  Kapay Kibadi; Marleen Boelaert; Alexandra G Fraga; Makanzu Kayinua; Adhemar Longatto-Filho; Jean-Bedel Minuku; Jean-Baptiste Mputu-Yamba; Jean-Jacques Muyembe-Tamfum; Jorge Pedrosa; Jean-Jacques Roux; Wayne M Meyers; Françoise Portaels
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

8.  Buruli ulcer lesions in HIV-positive patient.

Authors:  Kapay Kibadi; Robert Colebunders; Jean-Jacques Muyembe-Tamfum; Wayne M Meyers; Françoise Portaels
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

9.  Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon.

Authors:  Vanessa Christinet; Eric Comte; Laura Ciaffi; Peter Odermatt; Micaela Serafini; Annick Antierens; Ludovic Rossel; Alain-Bertrand Nomo; Patrick Nkemenang; Akoa Tsoungui; Cecile Delhumeau; Alexandra Calmy
Journal:  Open Forum Infect Dis       Date:  2014-05-21       Impact factor: 3.835

10.  Clinical Epidemiology of Buruli Ulcer from Benin (2005-2013): Effect of Time-Delay to Diagnosis on Clinical Forms and Severe Phenotypes.

Authors:  Carlos Capela; Ghislain E Sopoh; Jean G Houezo; René Fiodessihoué; Ange D Dossou; Patrício Costa; Alexandra G Fraga; João F Menino; Rita Silva-Gomes; Edgard M Ouendo; Fernando Rodrigues; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.